Strides Pharma Science Ltd.
Snapshot View

349.40 +1.80 ▲0.5%

17 August 2022, 10:26:58 AM
Volume: 31,232

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.strides.com
Market Cap 3,122.48 Cr.
Enterprise Value(EV) 5,727.08 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -43.53 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-06
Industry PE 32.22 Trailing Twelve Months Ending 2022-06
Book Value / Share 253.92 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.37 Calculated using Price: 347.70
Dividend Yield 0.72 Period Ending 2021-03
No. of Shares Subscribed 8.98 Cr. 89,803,714 Shares
FaceValue 10
Company Profile
The company's core competence is in the development and manufacture of wide range of niche and technically complex pharmaceutical products. The company is also among the world's largest soft gelatin capsule manufacturers.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.52%
1 Week
+1.04%
1 Month
+2.76%
3 Month
+15.10%
6 Month
-5.90%
1 Year
-45.02%
2 Year
-37.05%
5 Year
-61.87%
10 Year
-57.30%
9 years 2012-12 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 42.16 3.36 0.09 5.25 16.53 27.00 14.74 5.34 13.43
Return on Capital Employed (%) 21.08 7.76 10.92 7.54 10.75 16.07 8.65 6.01 11.47
Return on Assets (%) 14.07 1.48 0.04 2.03 5.79 9.59 5.22 2.00 5.57

Balance Sheet View Details >>

Particulars 10 years 2012-12 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 2,026 1,007 1,145 2,658 2,749 2,464 2,649 2,527 2,777 2,359
Non Curr. Liab. 901 306 286 2,760 2,049 2,067 2,343 814 1,264 966
Curr. Liab. 1,797 707 1,020 1,892 3,104 1,899 2,662 2,545 2,738 3,412
Minority Int. 72 76 19 50 134 155 153 67 37 24
Equity & Liab. 4,796 2,096 2,469 7,360 8,035 6,585 7,807 5,953 6,817 6,761
Non Curr. Assets 3,384 788 1,040 3,845 4,243 4,101 4,758 3,581 4,000 3,399
Curr. Assets 1,411 1,309 1,429 3,515 3,792 2,484 3,049 2,372 2,817 3,362
Misc. Exp. not W/O 1
Total Assets 4,796 2,096 2,469 7,360 8,035 6,585 7,807 5,953 6,817 6,761

Profit Loss View Details >>

Particulars 10 years 2012-12 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 962 1,341 1,196 2,862 3,826 3,344 3,108 2,981 3,316 3,322
Other Income 34 60 39 102 398 921 323 67 73 141
Total Income 996 1,401 1,234 2,965 4,224 4,265 3,431 3,048 3,389 3,463
Total Expenditure -861 -1,118 -967 -2,482 -3,309 -3,109 -2,812 -2,471 -2,689 -3,241
PBIDT 135 284 267 483 915 1,156 620 577 700 222
Interest -79 -109 -47 -168 -183 -196 -79 -156 -150 -190
Depreciation -31 -56 -64 -131 -199 -194 -172 -188 -206 -239
Taxation -11 -41 -148 -42 -51 -21 -14 -18 -32 171
Exceptional Items 700 -27 -7 -41 -36 -44 22 -78 43 -218
PAT 713 51 1 100 446 701 376 138 356 -253
Minority Interest -1 1 14 -46 -20 -5 6 11 10
Share Associate -5 0 -17 -46 -107 -98 -148
Other Related Items
Consolidated Net Profit 846 1,767 845 109 400 665 325 36 268 -391
Adjusted EPS 121 9 0 12 45 74 36 4 30 -44

Cash Flow View Details >>

Particulars 10 years 2011-12 Rs. Cr. 2012-12 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 457 134 -272 83 73 288 187 60 205 481
Cash Fr. Inv. -656 807 4,077 52 -2,225 -687 583 -148 1,306 -521
Cash Fr. Finan. 89 -990 -3,319 -421 2,944 338 -1,016 194 -1,709 -16
Net Change -110 -49 487 -286 792 -60 -246 106 -199 -55
Cash & Cash Eqvt 212 132 586 298 1,111 515 256 366 182 126

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 29.71 29.69 29.69 29.67 29.62 29.60 29.60 30.60 30.37
Public 70.29 70.31 70.31 70.33 70.38 70.40 70.40 69.40 69.63
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 46.84 37.04 40.38 32.56 26.02 26.02 37.84 56.67 62.20

Announcements View Details >>

Mon, 08 Aug 2022
Press Release
Strides Pharma Science Limited has informed the Exchange about press release dated 08-Aug-2022 titled Strides announces successful completion of US FDA inspection at its Singapore facility
Fri, 05 Aug 2022
Transcript of Analysts/Institutional Investor Meet/Con. Call
Strides Pharma Science Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call
Thu, 04 Aug 2022
Transcript of Analysts/Institutional Investor Meet/Con. Call
Strides Pharma Science Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call

Technical Scans View Details >>

Tue, 16 Aug 2022
High Increase 3 Months High Increase 3 Months
High Decrease 1 Year High Decrease 1 Year
Fri, 12 Aug 2022
Closing Above Previous High Closing Above Previous High
High Increase 3 Months High Increase 3 Months
High Decrease 1 Year High Decrease 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,443.18 920.00 +0.6%
Divi's Laboratories Ltd. 99,072.87 3,768.10 +1.0%
Cipla Ltd. 83,487.41 1,031.40 -0.3%
Dr. Reddy's Laboratories Ltd. 71,536.21 4,314.35 +0.4%
Apollo Hospitals Enterprise Ltd. 62,537.70 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. 53,261.16 1,561.30 -0.8%
Piramal Enterprises Ltd. 45,983.34 1,983.80 +3.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.42 920.00 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-06 31.92 3,768.10 +1.0%
Cipla Ltd. Consolidated 2022-06 33.44 1,031.40 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.91 4,314.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.76 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.33 1,561.30 -0.8%
Piramal Enterprises Ltd. Consolidated 2022-06 24.47 1,983.80 +3.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.38 920.00 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,768.10 +1.0%
Cipla Ltd. Consolidated 2022-06 3.87 1,031.40 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.53 4,314.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.52 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.31 1,561.30 -0.8%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,983.80 +3.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 920.00 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,768.10 +1.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.40 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,314.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,561.30 -0.8%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,983.80 +3.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.00 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,768.10 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.40 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,314.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,561.30 -0.8%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,983.80 +3.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.00 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,768.10 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.40 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,314.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,561.30 -0.8%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,983.80 +3.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 920.00 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,768.10 +1.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.40 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,314.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,561.30 -0.8%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,983.80 +3.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 920.00 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,768.10 +1.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.40 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,314.35 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,561.30 -0.8%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,983.80 +3.0%

FAQ's On Strides Pharma Science Ltd.

Can I Buy Strides Pharma Scien Shares now?

What is the Share Price of Strides Pharma Scien?

What is the Relative Strength Index (RSI) Value of Strides Pharma Scien?

What is the Market Capital (MCAP) of Strides Pharma Scien?

What are the key metrics to analyse Strides Pharma Scien?

What is the Price Performance of Strides Pharma Scien?